A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKANDAKARE, Edna Regina e PASSARELLI, Marisa. Obesidade e metabolismo de lipídeos. Tratado de obesidade. Tradução . Rio de Janeiro: Guanabara Koogan, 2025. . . Acesso em: 12 fev. 2026.
APA
Nakandakare, E. R., & Passarelli, M. (2025). Obesidade e metabolismo de lipídeos. In Tratado de obesidade. Rio de Janeiro: Guanabara Koogan.
NLM
Nakandakare ER, Passarelli M. Obesidade e metabolismo de lipídeos. In: Tratado de obesidade. Rio de Janeiro: Guanabara Koogan; 2025. [citado 2026 fev. 12 ]
Vancouver
Nakandakare ER, Passarelli M. Obesidade e metabolismo de lipídeos. In: Tratado de obesidade. Rio de Janeiro: Guanabara Koogan; 2025. [citado 2026 fev. 12 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JULIANI, Fabiana Cordeiro et al. Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL. 2025, Anais.. Oxford: Faculdade de Medicina, Universidade de São Paulo, 2025. p. 1-2. Disponível em: https://dx.doi.org/10.1093/eurheartj/ehaf784.4861. Acesso em: 12 fev. 2026.
APA
Juliani, F. C., Miname, M. H., Laurinavicius, A. G., Rocha, V. Z., Nakandakare, M., Passarelli, M., et al. (2025). Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL. In European Heart Journal (Vol. 46, p. 1-2). Oxford: Faculdade de Medicina, Universidade de São Paulo. doi:10.1093/eurheartj/ehaf784.4861
NLM
Juliani FC, Miname MH, Laurinavicius AG, Rocha VZ, Nakandakare M, Passarelli M, Bortolotto LA, Maranhão RC, Santos RD. Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL [Internet]. European Heart Journal. 2025 ; 46 1-2.[citado 2026 fev. 12 ] Available from: https://dx.doi.org/10.1093/eurheartj/ehaf784.4861
Vancouver
Juliani FC, Miname MH, Laurinavicius AG, Rocha VZ, Nakandakare M, Passarelli M, Bortolotto LA, Maranhão RC, Santos RD. Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL [Internet]. European Heart Journal. 2025 ; 46 1-2.[citado 2026 fev. 12 ] Available from: https://dx.doi.org/10.1093/eurheartj/ehaf784.4861
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Mariana Aparecida Redondano de et al. Efeito de metabólitos de compostos fenólicos de Passiflora tenuifila no efluxo lipídico em macrófagos. 2025, Anais.. São Paulo: Pró-Reitoria de Pesquisa da USP, 2025. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 12 fev. 2026.
APA
Almeida, M. A. R. de, Duarte, I. de A. E., Santos, D. R., Passarelli, M., & Hassimotto, N. M. A. (2025). Efeito de metabólitos de compostos fenólicos de Passiflora tenuifila no efluxo lipídico em macrófagos. In Resumos. São Paulo: Pró-Reitoria de Pesquisa da USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Almeida MAR de, Duarte I de AE, Santos DR, Passarelli M, Hassimotto NMA. Efeito de metabólitos de compostos fenólicos de Passiflora tenuifila no efluxo lipídico em macrófagos [Internet]. Resumos. 2025 ;[citado 2026 fev. 12 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Almeida MAR de, Duarte I de AE, Santos DR, Passarelli M, Hassimotto NMA. Efeito de metabólitos de compostos fenólicos de Passiflora tenuifila no efluxo lipídico em macrófagos [Internet]. Resumos. 2025 ;[citado 2026 fev. 12 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MICHALANI, Maria Luiza Estimo e PASSARELLI, Marisa e MACHADO, Ubiratan Fabres. Nuclear Factor-Kappa-B mediates the advanced glycation end product-induced repression of Slc2a4 gene expression in 3T3-L1 adipocytes. International Journal of Molecular Sciences, v. 25, n. 15, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/ijms25158242. Acesso em: 12 fev. 2026.
APA
Michalani, M. L. E., Passarelli, M., & Machado, U. F. (2024). Nuclear Factor-Kappa-B mediates the advanced glycation end product-induced repression of Slc2a4 gene expression in 3T3-L1 adipocytes. International Journal of Molecular Sciences, 25( 15), 14 . doi:10.3390/ijms25158242
NLM
Michalani MLE, Passarelli M, Machado UF. Nuclear Factor-Kappa-B mediates the advanced glycation end product-induced repression of Slc2a4 gene expression in 3T3-L1 adipocytes [Internet]. International Journal of Molecular Sciences. 2024 ; 25( 15): 14 .[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/ijms25158242
Vancouver
Michalani MLE, Passarelli M, Machado UF. Nuclear Factor-Kappa-B mediates the advanced glycation end product-induced repression of Slc2a4 gene expression in 3T3-L1 adipocytes [Internet]. International Journal of Molecular Sciences. 2024 ; 25( 15): 14 .[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/ijms25158242
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Monique de Fátima Mello et al. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease. Cells, v. 13, p. 1-19 art. 1327, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cells13161327. Acesso em: 12 fev. 2026.
APA
Santana, M. de F. M., Sawada, M. I. B. A. C., Souza Junior, D. R. de, Giacaglia, M. B., Reis, M., Xavier, J., et al. (2024). Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease. Cells, 13, 1-19 art. 1327. doi:10.3390/cells13161327
NLM
Santana M de FM, Sawada MIBAC, Souza Junior DR de, Giacaglia MB, Reis M, Xavier J, Giannella MLCC, Soriano FG, Gebrim LH, Ronsein GE, Passarelli M. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease [Internet]. Cells. 2024 ; 13 1-19 art. 1327.[citado 2026 fev. 12 ] Available from: https://dx.doi.org/10.3390/cells13161327
Vancouver
Santana M de FM, Sawada MIBAC, Souza Junior DR de, Giacaglia MB, Reis M, Xavier J, Giannella MLCC, Soriano FG, Gebrim LH, Ronsein GE, Passarelli M. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease [Internet]. Cells. 2024 ; 13 1-19 art. 1327.[citado 2026 fev. 12 ] Available from: https://dx.doi.org/10.3390/cells13161327
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSIS, Sayonara Ivana Santos de et al. The prolonged activation of the p65 subunit of the NF-Kappa-B nuclear factor sustains the persistent effect of advanced Glycation end products on inflammatory sensitization in macrophages. International Journal of Molecular Sciences, v. 25, n. 5, p. 16 , 2024Tradução . . Disponível em: https://doi.org/10.3390/ijms25052713. Acesso em: 12 fev. 2026.
APA
Assis, S. I. S. de, Amendola, L. S., Ferreira, G. da S., Santos, D. R., Santana, M. de F. M., Santana, K. G., et al. (2024). The prolonged activation of the p65 subunit of the NF-Kappa-B nuclear factor sustains the persistent effect of advanced Glycation end products on inflammatory sensitization in macrophages. International Journal of Molecular Sciences, 25( 5), 16 . doi:10.3390/ijms25052713
NLM
Assis SIS de, Amendola LS, Ferreira G da S, Santos DR, Santana M de FM, Santana KG, Okamoto MM, Iborra RT, Gianella MLCC, Barbeiro DF, Soriano FG, Passarelli M, Machado UF. The prolonged activation of the p65 subunit of the NF-Kappa-B nuclear factor sustains the persistent effect of advanced Glycation end products on inflammatory sensitization in macrophages [Internet]. International Journal of Molecular Sciences. 2024 ; 25( 5): 16 .[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/ijms25052713
Vancouver
Assis SIS de, Amendola LS, Ferreira G da S, Santos DR, Santana M de FM, Santana KG, Okamoto MM, Iborra RT, Gianella MLCC, Barbeiro DF, Soriano FG, Passarelli M, Machado UF. The prolonged activation of the p65 subunit of the NF-Kappa-B nuclear factor sustains the persistent effect of advanced Glycation end products on inflammatory sensitization in macrophages [Internet]. International Journal of Molecular Sciences. 2024 ; 25( 5): 16 .[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/ijms25052713
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Monique de Fátima Mello et al. Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer. International journal of molecular sciences, v. 24, n. 16, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55955. Acesso em: 12 fev. 2026.
APA
Santana, M. de F. M., Sawada, M. I. B. A. C., Santos, A. S., Reis, M., Xavier, J., Giannella, M. L. C. C., et al. (2023). Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer. International journal of molecular sciences, 24( 16). doi:10.3390/ijms241612762
NLM
Santana M de FM, Sawada MIBAC, Santos AS, Reis M, Xavier J, Giannella MLCC, Hirata AH de L, Gebrim LH, Soriano FG, Camacho CP, Passarelli M. Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer [Internet]. International journal of molecular sciences. 2023 ; 24( 16):[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55955
Vancouver
Santana M de FM, Sawada MIBAC, Santos AS, Reis M, Xavier J, Giannella MLCC, Hirata AH de L, Gebrim LH, Soriano FG, Camacho CP, Passarelli M. Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer [Internet]. International journal of molecular sciences. 2023 ; 24( 16):[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55955
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAWADA, Maria Isabela Bloise Alves Caldas et al. Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors. Scientific reports, v. 13, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54559. Acesso em: 12 fev. 2026.
APA
Sawada, M. I. B. A. C., Santana, M. de F. M., Reis, M., Assis, S. I. S. de, Pereira, L. A., Santos, D. R., et al. (2023). Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors. Scientific reports, 13( 1). doi:10.1038/s41598-023-35764-7
NLM
Sawada MIBAC, Santana M de FM, Reis M, Assis SIS de, Pereira LA, Santos DR, Nunes VS, Giannella MLCC, Gebrim LH, Passarelli M. Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors [Internet]. Scientific reports. 2023 ; 13( 1):[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54559
Vancouver
Sawada MIBAC, Santana M de FM, Reis M, Assis SIS de, Pereira LA, Santos DR, Nunes VS, Giannella MLCC, Gebrim LH, Passarelli M. Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors [Internet]. Scientific reports. 2023 ; 13( 1):[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54559
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Amarilis de Lima et al. The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52835. Acesso em: 12 fev. 2026.
APA
Campos, A. de L., Sawada, M. I. B. A. C., Santana, M. F. de M., Iborra, R. T., Assis, S. I. S. de, Reis, M., et al. (2023). The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer. Frontiers in oncology, 13. doi:10.3389/fonc.2023.1111094
NLM
Campos A de L, Sawada MIBAC, Santana MF de M, Iborra RT, Assis SIS de, Reis M, Carvalho JX de, Gebrim LH, Passarelli M. The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer [Internet]. Frontiers in oncology. 2023 ; 13[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52835
Vancouver
Campos A de L, Sawada MIBAC, Santana MF de M, Iborra RT, Assis SIS de, Reis M, Carvalho JX de, Gebrim LH, Passarelli M. The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer [Internet]. Frontiers in oncology. 2023 ; 13[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52835
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YONAMINE, Caio Yogi et al. Postmortem brains from subjects with Diabetes Mellitus display reduced GLUT4 expression and soma area in hippocampal neurons: potential involvement of inflammation. Cells, v. 12, n. 9, p. 1-21, 2023Tradução . . Disponível em: https://doi.org/10.3390/cells12091250. Acesso em: 12 fev. 2026.
APA
Yonamine, C. Y., Passarelli, M., Suemoto, C. K., Pasqualucci, C. A. G., Jacob-Filho, W., Alves, V. A. F., et al. (2023). Postmortem brains from subjects with Diabetes Mellitus display reduced GLUT4 expression and soma area in hippocampal neurons: potential involvement of inflammation. Cells, 12( 9), 1-21. doi:10.3390/cells12091250
NLM
Yonamine CY, Passarelli M, Suemoto CK, Pasqualucci CAG, Jacob-Filho W, Alves VAF, Marie SKN, Giannella MLC, Britto LRG de, Machado UF. Postmortem brains from subjects with Diabetes Mellitus display reduced GLUT4 expression and soma area in hippocampal neurons: potential involvement of inflammation [Internet]. Cells. 2023 ; 12( 9): 1-21.[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/cells12091250
Vancouver
Yonamine CY, Passarelli M, Suemoto CK, Pasqualucci CAG, Jacob-Filho W, Alves VAF, Marie SKN, Giannella MLC, Britto LRG de, Machado UF. Postmortem brains from subjects with Diabetes Mellitus display reduced GLUT4 expression and soma area in hippocampal neurons: potential involvement of inflammation [Internet]. Cells. 2023 ; 12( 9): 1-21.[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/cells12091250
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOYOSHIMA, Marcos Tadashi Kakitani et al. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study. Diabetology and Metabolic Syndrome, v. 15, p. 1-14 art. 42, 2023Tradução . . Disponível em: https://doi.org/10.1186/s13098-023-01007-y. Acesso em: 12 fev. 2026.
APA
Toyoshima, M. T. K., Santana, M. de F. M., Silva, A. R. M., Mello, G. B., Bezerra, D. P. S., Góes, M. F. S., et al. (2023). Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study. Diabetology and Metabolic Syndrome, 15, 1-14 art. 42. doi:10.1186/s13098-023-01007-y
NLM
Toyoshima MTK, Santana M de FM, Silva ARM, Mello GB, Bezerra DPS, Góes MFS, Bosco AA, Caramelli B, Ronsein GE, Giannella MLC, Passarelli M. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study [Internet]. Diabetology and Metabolic Syndrome. 2023 ; 15 1-14 art. 42.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1186/s13098-023-01007-y
Vancouver
Toyoshima MTK, Santana M de FM, Silva ARM, Mello GB, Bezerra DPS, Góes MFS, Bosco AA, Caramelli B, Ronsein GE, Giannella MLC, Passarelli M. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study [Internet]. Diabetology and Metabolic Syndrome. 2023 ; 15 1-14 art. 42.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1186/s13098-023-01007-y
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Francis Ribeiro de et al. Coronary inflammation by computed tomography pericoronary fat attenuation and increased cytokines in young male anabolic androgenic steroid users. Arquivos Brasileiros de Cardiologia, v. 120, n. 11, p. 1-7 art. e20220822, 2023Tradução . . Disponível em: https://dx.doi.org/10.36660/abc.20220822. Acesso em: 12 fev. 2026.
APA
Souza, F. R. de, Rochitte, C. E., Silva, D. C., Sampaio, B., Passarelli, M., Santos, M. R. dos, et al. (2023). Coronary inflammation by computed tomography pericoronary fat attenuation and increased cytokines in young male anabolic androgenic steroid users. Arquivos Brasileiros de Cardiologia, 120( 11), 1-7 art. e20220822. doi:10.36660/abc.20220822
NLM
Souza FR de, Rochitte CE, Silva DC, Sampaio B, Passarelli M, Santos MR dos, Fonseca GWP da, Battaglia Filho AC, Correa KTS, Val RM do, Yonamine M, Pereira RMR, Negrão CE, Kalil Filho R, Alves MJ de NN. Coronary inflammation by computed tomography pericoronary fat attenuation and increased cytokines in young male anabolic androgenic steroid users [Internet]. Arquivos Brasileiros de Cardiologia. 2023 ; 120( 11): 1-7 art. e20220822.[citado 2026 fev. 12 ] Available from: https://dx.doi.org/10.36660/abc.20220822
Vancouver
Souza FR de, Rochitte CE, Silva DC, Sampaio B, Passarelli M, Santos MR dos, Fonseca GWP da, Battaglia Filho AC, Correa KTS, Val RM do, Yonamine M, Pereira RMR, Negrão CE, Kalil Filho R, Alves MJ de NN. Coronary inflammation by computed tomography pericoronary fat attenuation and increased cytokines in young male anabolic androgenic steroid users [Internet]. Arquivos Brasileiros de Cardiologia. 2023 ; 120( 11): 1-7 art. e20220822.[citado 2026 fev. 12 ] Available from: https://dx.doi.org/10.36660/abc.20220822
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUTRA, Luiz A et al. Discovery of (E)-4-styrylphenoxy-propanamide: a dual PPAR alpha/gamma partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice. Bioorganic chemistry, v. 120, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2022.105600. Acesso em: 12 fev. 2026.
APA
Dutra, L. A., Lacerda, M. G., Inacio, M. D., Martins, J. W. L., Silva, A. C. L., Silva, P. B. da, et al. (2022). Discovery of (E)-4-styrylphenoxy-propanamide: a dual PPAR alpha/gamma partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice. Bioorganic chemistry, 120. doi:10.1016/j.bioorg.2022.105600
NLM
Dutra LA, Lacerda MG, Inacio MD, Martins JWL, Silva ACL, Silva PB da, Chorilli M, Amato AA, Baviera AM, Passarelli M. Discovery of (E)-4-styrylphenoxy-propanamide: a dual PPAR alpha/gamma partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice [Internet]. Bioorganic chemistry. 2022 ; 120[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.bioorg.2022.105600
Vancouver
Dutra LA, Lacerda MG, Inacio MD, Martins JWL, Silva ACL, Silva PB da, Chorilli M, Amato AA, Baviera AM, Passarelli M. Discovery of (E)-4-styrylphenoxy-propanamide: a dual PPAR alpha/gamma partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice [Internet]. Bioorganic chemistry. 2022 ; 120[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.bioorg.2022.105600
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCHI, Ana Paula Garcia et al. Aerobic exercise training reduces atherogenesis induced by Low-Sodium diet in LDL receptor knockout mice. Antioxidants, v. 11, n. 10, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/antiox11102023. Acesso em: 12 fev. 2026.
APA
Bochi, A. P. G., Ferreira, G. da S., Bianco, V. D., Pinto, P. R., Rodrigues, L. G., Trevisani, M. da S., et al. (2022). Aerobic exercise training reduces atherogenesis induced by Low-Sodium diet in LDL receptor knockout mice. Antioxidants, 11( 10), 1-16. doi:10.3390/antiox11102023
NLM
Bochi APG, Ferreira G da S, Bianco VD, Pinto PR, Rodrigues LG, Trevisani M da S, Furukawa LNS, Bispo KCS, Silva AA da, Velosa APP, Nakandakare ER, Machado UF, Teodoro WPR, Passarelli M, Catanozi S. Aerobic exercise training reduces atherogenesis induced by Low-Sodium diet in LDL receptor knockout mice [Internet]. Antioxidants. 2022 ; 11( 10): 1-16.[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/antiox11102023
Vancouver
Bochi APG, Ferreira G da S, Bianco VD, Pinto PR, Rodrigues LG, Trevisani M da S, Furukawa LNS, Bispo KCS, Silva AA da, Velosa APP, Nakandakare ER, Machado UF, Teodoro WPR, Passarelli M, Catanozi S. Aerobic exercise training reduces atherogenesis induced by Low-Sodium diet in LDL receptor knockout mice [Internet]. Antioxidants. 2022 ; 11( 10): 1-16.[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/antiox11102023
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKANDAKARE, Edna Regina e PASSARELLI, Marisa. Dislipidemias. Endocrinologia e Metabologia. Tradução . Rio de Janeiro: Atheneu, 2022. . . Acesso em: 12 fev. 2026.
APA
Nakandakare, E. R., & Passarelli, M. (2022). Dislipidemias. In Endocrinologia e Metabologia. Rio de Janeiro: Atheneu.
NLM
Nakandakare ER, Passarelli M. Dislipidemias. In: Endocrinologia e Metabologia. Rio de Janeiro: Atheneu; 2022. [citado 2026 fev. 12 ]
Vancouver
Nakandakare ER, Passarelli M. Dislipidemias. In: Endocrinologia e Metabologia. Rio de Janeiro: Atheneu; 2022. [citado 2026 fev. 12 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOLDBAUM, Tatiana Silva et al. Urgências em endocrinologia. Endocrinologia e Metabologia. Tradução . Rio de Janeiro: Atheneu, 2022. . . Acesso em: 12 fev. 2026.
APA
Goldbaum, T. S., Admoni, S. N., Zanoni, P. H., Letaif, L. S. H., Carvalho, D. F. de, & Mendonca, B. B. de. (2022). Urgências em endocrinologia. In Endocrinologia e Metabologia. Rio de Janeiro: Atheneu.
NLM
Goldbaum TS, Admoni SN, Zanoni PH, Letaif LSH, Carvalho DF de, Mendonca BB de. Urgências em endocrinologia. In: Endocrinologia e Metabologia. Rio de Janeiro: Atheneu; 2022. [citado 2026 fev. 12 ]
Vancouver
Goldbaum TS, Admoni SN, Zanoni PH, Letaif LSH, Carvalho DF de, Mendonca BB de. Urgências em endocrinologia. In: Endocrinologia e Metabologia. Rio de Janeiro: Atheneu; 2022. [citado 2026 fev. 12 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSARELLI, Marisa e YOKOYAMA, Shinji e SPOSITO, Andrei Carvalho. Beyond cardiovascular disease.[editorial]: challenging new pathways in lipid and lipoprotein metabolism. Frontiers in cell and developmental biology. Lausanne: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fcell.2022.963463. Acesso em: 12 fev. 2026. , 2022
APA
Passarelli, M., Yokoyama, S., & Sposito, A. C. (2022). Beyond cardiovascular disease.[editorial]: challenging new pathways in lipid and lipoprotein metabolism. Frontiers in cell and developmental biology. Lausanne: Faculdade de Medicina, Universidade de São Paulo. doi:10.3389/fcell.2022.963463
NLM
Passarelli M, Yokoyama S, Sposito AC. Beyond cardiovascular disease.[editorial]: challenging new pathways in lipid and lipoprotein metabolism [Internet]. Frontiers in cell and developmental biology. 2022 ; 10[citado 2026 fev. 12 ] Available from: https://doi.org/10.3389/fcell.2022.963463
Vancouver
Passarelli M, Yokoyama S, Sposito AC. Beyond cardiovascular disease.[editorial]: challenging new pathways in lipid and lipoprotein metabolism [Internet]. Frontiers in cell and developmental biology. 2022 ; 10[citado 2026 fev. 12 ] Available from: https://doi.org/10.3389/fcell.2022.963463
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSARELLI, Marisa e MACHADO, Ubiratan Fabres. AGEs-induced and endoplasmic reticulum stress/inflammation-mediated regulation of GLUT4 expression and atherogenesis in diabetes mellitus. Cells, v. 11, n. 1, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/cells11010104. Acesso em: 12 fev. 2026.
APA
Passarelli, M., & Machado, U. F. (2022). AGEs-induced and endoplasmic reticulum stress/inflammation-mediated regulation of GLUT4 expression and atherogenesis in diabetes mellitus. Cells, 11( 1), 1-20. doi:10.3390/cells11010104
NLM
Passarelli M, Machado UF. AGEs-induced and endoplasmic reticulum stress/inflammation-mediated regulation of GLUT4 expression and atherogenesis in diabetes mellitus [Internet]. Cells. 2022 ; 11( 1): 1-20.[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/cells11010104
Vancouver
Passarelli M, Machado UF. AGEs-induced and endoplasmic reticulum stress/inflammation-mediated regulation of GLUT4 expression and atherogenesis in diabetes mellitus [Internet]. Cells. 2022 ; 11( 1): 1-20.[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/cells11010104
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Raphael de Souza et al. Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques. Diabetes and Vascular Disease Research, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1177/14791641221085269. Acesso em: 12 fev. 2026.
APA
Pinto, R. de S., Ferreira, G. da S., Silvestre, G. C. R., Santana, M. de F. M., Nunes, V. S., Ledesma, L., et al. (2022). Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques. Diabetes and Vascular Disease Research, 1-9. doi:10.1177/14791641221085269
NLM
Pinto R de S, Ferreira G da S, Silvestre GCR, Santana M de FM, Nunes VS, Ledesma L, Pinto PR, Assis SIS de, Machado UF, Silva ES da, Passarelli M. Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques [Internet]. Diabetes and Vascular Disease Research. 2022 ; 1-9.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1177/14791641221085269
Vancouver
Pinto R de S, Ferreira G da S, Silvestre GCR, Santana M de FM, Nunes VS, Ledesma L, Pinto PR, Assis SIS de, Machado UF, Silva ES da, Passarelli M. Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques [Internet]. Diabetes and Vascular Disease Research. 2022 ; 1-9.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1177/14791641221085269
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUTRA, Luiz A. et al. Discovery of (E)-4-styrylphenoxy-propanamide: a dual PPARα/γ partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice. Bioorganic Chemistry, v. 120, p. 105600-1-105600-12 + supplementary material: S1-S44, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2022.105600. Acesso em: 12 fev. 2026.
APA
Dutra, L. A., Lacerda, M. G., Inácio, M. D., Martins, J. W. L., Silva, A. C. L., Silva, P. B. da, et al. (2022). Discovery of (E)-4-styrylphenoxy-propanamide: a dual PPARα/γ partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice. Bioorganic Chemistry, 120, 105600-1-105600-12 + supplementary material: S1-S44. doi:10.1016/j.bioorg.2022.105600
NLM
Dutra LA, Lacerda MG, Inácio MD, Martins JWL, Silva ACL, Silva PB da, Chorilli M, Amato AA, Baviera AM, Passarelli M, Guido RVC, Santos JL dos. Discovery of (E)-4-styrylphenoxy-propanamide: a dual PPARα/γ partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice [Internet]. Bioorganic Chemistry. 2022 ; 120 105600-1-105600-12 + supplementary material: S1-S44.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.bioorg.2022.105600
Vancouver
Dutra LA, Lacerda MG, Inácio MD, Martins JWL, Silva ACL, Silva PB da, Chorilli M, Amato AA, Baviera AM, Passarelli M, Guido RVC, Santos JL dos. Discovery of (E)-4-styrylphenoxy-propanamide: a dual PPARα/γ partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice [Internet]. Bioorganic Chemistry. 2022 ; 120 105600-1-105600-12 + supplementary material: S1-S44.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.bioorg.2022.105600
; Passarelli, Marisa 
